A pioneer of Western medicine after Shanghai opened as a treaty port
Renji Hospital was founded, beginning a tradition of clinical care, teaching and research that continues today.
Affiliated with Shanghai Jiao Tong University School of MedicineRenji Hospital
First nationally for gastroenterology reputation: Renji advances medicine through original research.
Founded in 1844, Renji Hospital ranked first in gastroenterology and third in rheumatology in the 2023 Fudan National Specialty Reputation Rankings. Its gastrointestinal cancer risk detection and prevention work and pediatric liver transplantation techniques both received 2018 National Science and Technology Progress Second Prizes. Its lupus research spans the national 973 program and Cell. From precancerous lesions to immune disorders and pediatric end-stage liver disease, Renji's strengths rest on defined specialty standing and medical contributions.
Shanghai, China
A long medical heritage, with three nationally influential areas of expertise.
Renji's importance extends beyond its founding date. Gastroenterology studies how to identify and prevent gastrointestinal cancer; rheumatology investigates lupus immune mechanisms; liver surgery develops pediatric transplantation techniques and management standards. Clinical challenges, original research and national dissemination connect here.
National reputation in gastroenterology and rheumatology, and national awards in gastrointestinal cancer and pediatric liver transplantation, provide concrete measures of its strengths.
National specialty reputation and medical achievements
Rankings follow the 2023 Fudan National Specialty Reputation Rankings
GastroenterologyNo. 1
2023 national specialty reputation
RheumatologyNo. 3
2023 national specialty reputation
Gastrointestinal cancer and pediatric liver transplantationTwo National Second Prizes
2018 National Science and Technology Progress Awards
Reputation rankings, national science awards and overall hospital grades use different assessment criteria and are shown separately.
Gastroenterology: a national key discipline
Gastroenterology is a national key discipline and national key clinical specialty. Its key laboratory supports research into gastrointestinal cancer development, precancerous lesions and clinical translation.
National science awards for gastrointestinal cancer and pediatric liver transplantation
In 2018, Fang Jingyuan's gastrointestinal cancer risk detection and prevention work and Xia Qiang's pediatric liver transplantation techniques each received a National Science and Technology Progress Second Prize.
National clinical and research platforms in rheumatology and immunology
Rheumatology is a national key clinical specialty, undertakes national 973 research on systemic lupus erythematosus, and organizes collaboration through the Shanghai Clinical Research Center for Rheumatic and Immune Diseases.
Establishment of rheumatology, focused on systemic lupus erythematosus
Building on earlier autoimmune research by Chen Shunle and colleagues, the department was formally established with lupus as a long-term clinical and research focus.
Two areas of innovation receive national science awards
Key technologies in gastrointestinal cancer risk detection and prevention and pediatric liver transplantation each received a National Science and Technology Progress Second Prize, presented in 2019.
Adenoma recurrence prevention research in an international journal
A multicenter randomized controlled trial led by Fang Jingyuan's team was published in The Lancet Gastroenterology & Hepatology, studying berberine's effect on recurrence after adenoma removal.
Leading specialties,
built on medical achievements.
Explore Renji Hospital's contributions in each field, from specialty standing to notable achievements, and the conditions this expertise supports.
No. 1 nationally for specialty reputation
2023 Fudan National Specialty Reputation Rankings · Gastroenterology
The nationally first-ranked gastroenterology specialty connects gastrointestinal cancer risk identification, precancerous lesion research and endoscopic techniques into a continuous system of expertise. Its contributions include national science awards, multicenter clinical trials and clinical consensus.
Establishing a research framework for gastrointestinal cancer risk detection and prevention
2018 · National Science and Technology Progress Second PrizeFang Jingyuan's team received a national award for research on gastrointestinal cancer mechanisms, early recognition and prevention.
Studying drug prevention after adenoma removal
2020 · Multicenter randomized controlled researchAs corresponding author, Fang Jingyuan led a seven-hospital comparison of berberine and placebo, published in The Lancet Gastroenterology & Hepatology.
Clinical reference books on narrow-band imaging and early cancer recognition
Endoscopic recognition · Sharing technical expertiseLi Xiaobo edited a narrow-band imaging atlas, a magnifying endoscopy diagnostic manual and case analyses of early upper gastrointestinal cancer, connecting image-based lesion recognition with endoscopic treatment.
National key discipline and key clinical specialty
Long-standing clinical care and research in gastrointestinal cancer, digestive endoscopy and related digestive diseases.
National Health Commission Key Laboratory of Gastroenterology
Supporting research into gastrointestinal cancer mechanisms, the intestinal microbiome and translation in precancerous disease.
What conditions can this expertise help address?
Gastrointestinal precancerous lesions, early cancers and complex polyps require assessment of endoscopic images, pathology and prior resection records. Specialist teams support risk assessment, lesion recognition, endoscopic treatment and long-term management.
No. 3 nationally for specialty reputation
2023 Fudan National Specialty Reputation Rankings · Rheumatology
Formally established in 1979, the department has long focused on systemic lupus erythematosus. Its national 973 work, international basic research and clinical guidelines underpin Renji's academic influence in rheumatology and immunology.
Leading research into lupus mechanisms and new diagnostic and treatment strategies
2014 · National 973 programShen Nan serves as chief scientist, bringing multidisciplinary teams together to study genetics, immune regulation, biomarkers and therapeutic targets.
Revealing links between circular RNA and innate immune regulation
2019 · Research in CellShen Nan collaborated with Chen Lingling and Yang Li's teams on circular RNA stability and PKR activation, serving as a co-corresponding author.
National key clinical specialty
A clinical and research platform for rheumatic and immune diseases, with disease-specific specialist areas.
Shanghai Clinical Research Center for Rheumatic and Immune Diseases
Based at Renji, the center connects clinical research, sample resources and translation through multicenter collaboration.
What conditions can this expertise help address?
The department covers systemic lupus erythematosus, rheumatoid arthritis, Sjögren's syndrome, inflammatory myopathies and vasculitis. Featured specialist Shen Nan's personal focus is molecular diagnosis and targeted treatment research in lupus.
A team associated with a National Science and Technology Progress Second Prize
2018 · Development and clinical dissemination of key pediatric liver transplantation technologies
Renji's major contribution to pediatric liver transplantation is a transferable technical framework for reconstructing small vessels, matching donors and recipients, and postoperative immune management. Xia Qiang's team advances the field through original techniques and Chinese clinical standards.
Establishing key technologies for pediatric liver transplantation
2018 · National Science and Technology Progress Second PrizeWith Xia Qiang as first-ranked contributor, the team developed a series of advances in surgical techniques, immune monitoring and postoperative management.
Autologous portal vein patches and pediatric liver transplantation guidelines
Original vascular reconstruction · Clinical standardsThe team pioneered autologous portal vein patching for reconstruction of narrowed portal veins and led China's first clinical guideline for pediatric liver transplantation.
National training base for liver transplant physicians
Combining pediatric liver transplantation techniques, perioperative management and professional training.
Organ transplantation and immunology research platforms
Clinical and basic research through the Shanghai Organ Transplantation and Immunology Engineering Technology Research Center and related institutes.
What conditions can this expertise help address?
Relevant teams assess surgery for pediatric end-stage liver disease, biliary atresia, and benign and malignant liver tumors. The hospital must assess transplant indications, donor and recipient conditions and subsequent care according to regulations and clinical requirements.
Meet the specialists
through their achievements.
Discover the specialists' contributions and the conditions and treatments they focus on.
Showing 4 representative specialists
Fang Jingyuan
Gastroenterology and gastrointestinal endoscopy
Member of the Chinese Academy of Sciences · Chief physician · Professor
Elected to the Chinese Academy of Sciences in 2025 · First-ranked contributor to two National Science and Technology Progress Second Prizes
Ask about this doctorA national science award recipient building evidence for gastrointestinal cancer risk detection and prevention
He has long treated gastrointestinal cancer and precancerous diseases, combining intestinal microbiome research, carcinogenesis mechanisms and clinical prevention trials to study identification and intervention before cancer develops.
Two National Science and Technology Progress Second Prizes
As first-ranked contributor, he received the 2008 and 2018 National Science and Technology Progress Second Prizes. The 2018 work focused on gastrointestinal cancer risk detection, prevention and mechanisms of development.
Leading a randomized trial of adenoma recurrence prevention
As corresponding author, he organized a multicenter double-blind study whose 2020 results examined berberine for prevention of recurrence after adenoma removal, and led related Chinese consensus work.
Conditions and treatment expertise
- Gastrointestinal precancerous disease
- Diagnosis, risk assessment and preventive management of gastritis, gastrointestinal precancerous lesions, colorectal adenomas and related conditions.
- Early diagnosis and comprehensive gastrointestinal cancer care
- Clinical care and translational research in early detection, clinical assessment and combined treatment of gastrointestinal cancer.
More professional experience and consultation information
The receiving doctor, campus and appointment time depend on hospital arrangements.
Li Xiaobo
Gastroenterology and gastrointestinal endoscopy
Chief physician
Sixth-ranked contributor to a 2018 National Science and Technology Progress Second Prize · Editor of gastrointestinal endoscopy reference books
Ask about this doctorA national award-winning team member specializing in endoscopic care for early gastrointestinal cancer
He focuses on endoscopic diagnosis and treatment of early digestive tract cancers and polyps, combining narrow-band imaging, magnifying endoscopy and endoscopic resection.
National Science and Technology Progress Second Prize · Sixth-ranked contributor
He contributed to the award-winning work on new discoveries in gastrointestinal cancer risk detection, prevention and development and their clinical applications.
Editing clinical references on early cancer and narrow-band imaging
He edited an atlas of narrow-band imaging, a magnifying endoscopy manual for early gastrointestinal cancer diagnosis and case analyses of early upper gastrointestinal cancer.
Conditions and treatment expertise
- Recognition of early gastrointestinal cancer
- Using narrow-band imaging, magnifying endoscopy and related techniques to identify early lesions and assess diagnosis.
- Endoscopic resection of polyps and early lesions
- Techniques include electrosurgical polypectomy, endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD).
More professional experience and consultation information
The receiving doctor, campus and appointment time depend on hospital arrangements.
Shen Nan
Rheumatology and immunology
Chief physician · Professor · Doctoral supervisor
National 973 project chief scientist · Edmund Dubois Memorial Award recipient
Ask about this doctorLeading national 973 lupus research and uncovering key pathways in autoimmune disease
His work in systemic lupus erythematosus spans molecular diagnosis, genetic mechanisms and targeted treatment research, advancing immunological discoveries toward translational research and clinical trials.
Lupus 973 project chief scientist · 2014
He led research into systemic lupus erythematosus mechanisms and new diagnostic and treatment strategies, coordinating genetics, immunology and clinical teams.
Co-corresponding author of research in Cell · 2019
With collaborating teams, he showed how circular RNA structure and stability contribute to innate immune PKR regulation, providing mechanistic evidence for understanding abnormal immunity in lupus.
Conditions and treatment expertise
- Specialist assessment of systemic lupus erythematosus
- Diagnostic and treatment research considering molecular disease features, activity and individual differences.
- Targeted treatment research in autoimmune disease
- Molecular diagnosis, basic-to-clinical translation and clinical research on innovative medicines. The research team determines eligibility for each study.
More professional experience and consultation information
The receiving doctor, campus and appointment time depend on hospital arrangements.
Xia Qiang
Liver surgery and pediatric liver transplantation
Member of the Chinese Academy of Engineering · Chief physician · Professor
First-ranked contributor to a 2018 National Science and Technology Progress Second Prize
Ask about this doctorPioneering pediatric liver transplant techniques, vascular reconstruction and care standards
He has long focused on pediatric end-stage liver disease, liver surgery and transplantation, studying small-vessel reconstruction, perioperative management and immune monitoring.
National Science and Technology Progress Second Prize · 2018
As first-ranked contributor, he led the development and dissemination of key pediatric liver transplantation technologies.
Original portal vein repair and Chinese guidelines
He led the team's autologous portal vein patch reconstruction work and chaired development of China's first clinical guideline for pediatric liver transplantation.
Conditions and treatment expertise
- Pediatric end-stage liver disease
- Surgical and transplant assessment for severe childhood liver disease such as biliary atresia, and related perioperative management.
- Benign and malignant liver tumors
- Surgical diagnosis and treatment of liver tumors, and specialist assessment in adult and pediatric liver transplantation.
More professional experience and consultation information
The receiving doctor, campus and appointment time depend on hospital arrangements.
These profiles describe professional expertise and notable experience. The doctor, campus and appointment time are confirmed when arranging care.
Want to learn about Renji Hospital?
Contact us directly.
Tell eastmedgo about the specialty, doctor or care question that matters to you, through WhatsApp or email.
Initial service inquiries are free. Medical assessments and treatment recommendations are provided by the receiving hospital and doctors.
Related reading
Medical guides related to this hospital’s specialties.
Gastroenterology and gastrointestinal endoscopy
EMR, ESD or surgery for an early gastric lesion: planning a Shanghai assessment
Compare endoscopic removal and surgery for an early stomach lesion, understand what changes the decision, and prepare a focused assessment in Shanghai.
Read articleGastric atrophy, intestinal metaplasia or dysplasia: reviewing the report before Shanghai care
Understand why gastric biopsy wording, biopsy locations, H. pylori and family history lead to different assessment and surveillance decisions.
Read article